drugset / Trial / NCT00379028

Airway Clearance Study

NCT00379028

Phase 4 Completed 54 enrolled AstraZeneca
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of the study is to evaluate how the airways in COPD patients, compared to healthy volunteers, absorb steroid drugs from Symbicort Turbuhaler and Seretide Diskus. The blood concentrations of the steroids will be used as surrogate marker.

Timeline

Start
2006-09
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 400 ug Inhaled
Subject Fluticasone Other / unclassified 500 ug Inhaled
Subject Formoterol Other / unclassified 12 ug Inhaled
Subject Salmeterol Other / unclassified 50 ug Inhaled